Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

267.47

-15.68 (-5.54%)

At close: Jul 17, 2026, 4:00 PM EDT

269.00

+1.53 (0.57%)

After-hours: Jul 17, 2026, 4:50 PM EDT

Alnylam Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,287	3,714	2,248	1,828	1,037	844.29
Revenue Growth (YoY)	82.57%	65.19%	22.97%	76.23%	22.88%	71.31%
Cost of Revenue	821.95	681.87	323.37	310.41	168.82	140.14
Gross Profit	3,465	3,032	1,925	1,518	868.6	704.14
Selling, General & Admin	1,293	1,211	975.53	795.65	770.66	620.64
Research & Development	1,420	1,320	1,126	1,004	883.02	792.16
Total Operating Expenses	2,713	2,530	2,102	1,800	1,654	1,413
Operating Income	752.14	501.58	-176.89	-282.18	-785.07	-708.65
Interest Income	109.4	111.47	121.99	95.56	24.81	1.58
Interest Expense	-283.27	-252.63	-141.86	-121.22	-155.97	-143.02
Other Non-Operating Income (Expense)	-4.3	-37.27	-180.62	-125.68	-210.76	-2.05
Total Non-Operating Income (Expense)	-178.17	-178.43	-200.49	-151.34	-341.92	-143.49
Pretax Income	586.4	323.15	-377.38	-433.52	-1,127	-852.14
Provision for Income Taxes	9.18	9.41	-99.22	6.73	4.16	0.68
Net Income	577.22	313.75	-278.16	-440.24	-1,131	-852.82
Net Income to Common	577.22	313.75	-278.16	-440.24	-1,131	-852.82
Shares Outstanding (Basic)	132	131	128	125	122	118
Shares Outstanding (Diluted)	136	135	128	125	122	118
Shares Change (YoY)	5.52%	5.51%	2.20%	2.64%	2.73%	3.01%
EPS (Basic)	3.79	2.39	-2.18	-3.52	-9.30	-7.20
EPS (Diluted)	3.66	2.33	-2.18	-3.52	-9.30	-7.20
Free Cash Flow	643.34	465.38	-42.59	41.95	-613.33	-718.07
Free Cash Flow Growth	38.24%	-	-	-	-	-
Free Cash Flow Per Share	4.74	3.46	-0.33	0.34	-5.04	-6.06
Gross Margin	80.83%	81.64%	85.62%	83.02%	83.73%	83.40%
Operating Margin	17.54%	13.51%	-7.87%	-15.43%	-75.68%	-83.94%
Profit Margin	13.46%	8.45%	-12.37%	-24.08%	-109.04%	-101.01%
FCF Margin	15.01%	12.53%	-1.89%	2.29%	-59.12%	-85.05%
EBITDA	806.94	557.24	-120.22	-228.12	-740.6	-661.09
EBITDA Margin	18.82%	15.00%	-5.35%	-12.48%	-71.39%	-78.30%
EBIT	752.14	501.58	-176.89	-282.18	-785.07	-708.65
EBIT Margin	17.54%	13.51%	-7.87%	-15.43%	-75.68%	-83.94%
Effective Tax Rate	1.57%	2.91%	26.29%	-1.55%	-0.37%	-0.08%

SEC Filings: 10-K · 10-Q